You can:
Name | Glucagon-like peptide 2 receptor |
---|---|
Species | Homo sapiens (Human) |
Gene | GLP2R |
Synonym | GLP-2R GLP-2-R GLP-2 receptor |
Disease | Diarrhea Gastrointestinal disease Short bowel syndrome Osteoporosis Inflammatory bowel disease |
Length | 553 |
Amino acid sequence | MKLGSSRAGPGRGSAGLLPGVHELPMGIPAPWGTSPLSFHRKCSLWAPGRPFLTLVLLVSIKQVTGSLLEETTRKWAQYKQACLRDLLKEPSGIFCNGTFDQYVCWPHSSPGNVSVPCPSYLPWWSEESSGRAYRHCLAQGTWQTIENATDIWQDDSECSENHSFKQNVDRYALLSTLQLMYTVGYSFSLISLFLALTLLLFLRKLHCTRNYIHMNLFASFILRTLAVLVKDVVFYNSYSKRPDNENGWMSYLSEMSTSCRSVQVLLHYFVGANYLWLLVEGLYLHTLLEPTVLPERRLWPRYLLLGWAFPVLFVVPWGFARAHLENTGCWTTNGNKKIWWIIRGPMMLCVTVNFFIFLKILKLLISKLKAHQMCFRDYKYRLAKSTLVLIPLLGVHEILFSFITDDQVEGFAKLIRLFIQLTLSSFHGFLVALQYGFANGEVKAELRKYWVRFLLARHSGCRACVLGKDFRFLGKCPKKLSEGDGAEKLRKLQPSLNSGRLLHLAMRGLGELGAQPQQDHARWPRGSSLSECSEGDVTMANTMEEILEESEI |
UniProt | O95838 |
Protein Data Bank | N/A |
GPCR-HGmod model | N/A |
3D structure model | No available structures or models |
BioLiP | N/A |
Therapeutic Target Database | T34843 |
ChEMBL | CHEMBL5844 |
IUPHAR | N/A |
DrugBank | N/A |
Name | CHEMBL3822792 |
---|---|
Molecular formula | C178H268N44O52 |
IUPAC name | (4S)-5-[[1-[[(2R)-1-[[(2S,3R)-1-[[(2S,3S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S,3S)-1-[[(2S)-4-amino-1-[[(2S)-1-[[(2S)-1-[[(2S,3S)-1-[[(2S)-5-amino-1-[[(2S,3R)-1-[[(2S)-6-amino-1-[[(2S,3S)-1-[[(2S,3R)-1-[[(2S)-3-carboxy-1-oxo-1-(pyridin-4-ylmethylamino)propan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-3-methyl-1-oxopentan-2-yl]amino]-1-oxohexan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-3-methyl-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-1,4-dioxobutan-2-yl]amino]-3-methyl-1-oxopentan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-3-carboxy-1-oxopropan-2-yl]amino]-5-carbamimidamido-1-oxopentan-2-yl]amino]-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-carboxy-1-oxopropan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-methyl-1-oxopentan-2-yl]amino]-3-hydroxy-1-oxobutan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-1-oxohexan-2-yl]amino]-4-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[2-[[(2S)-2-[[2-[[(2S)-2-amino-3-(1H-imidazol-5-yl)propanoyl]amino]acetyl]amino]-3-carboxypropanoyl]amino]acetyl]amino]-3-hydroxypropanoyl]amino]-3-phenylpropanoyl]amino]-3-hydroxypropanoyl]amino]-3-carboxypropanoyl]amino]-5-oxopentanoic acid |
Molecular weight | 3856.36 |
Hydrogen bond acceptor | 57 |
Hydrogen bond donor | 53 |
XlogP | -8.3 |
Synonyms | BDBM50183892 |
Inchi Key | KYDDZYOCUWWDQS-UEFHZNDXSA-N |
Inchi ID | InChI=1S/C178H268N44O52/c1-23-28-50-109(198-154(251)113(55-57-134(232)233)199-163(260)125(76-137(238)239)211-170(267)129(85-224)215-160(257)118(68-100-43-32-29-33-44-100)207-169(266)128(84-223)196-133(231)83-191-150(247)123(74-135(234)235)195-132(230)82-190-149(246)107(180)72-105-81-186-86-192-105)152(249)205-120(70-102-47-36-31-37-48-102)168(265)221-146(99(22)227)177(274)219-142(93(16)26-4)173(270)212-116(66-89(10)11)159(256)210-127(78-139(242)243)164(261)203-115(65-88(8)9)158(255)202-114(64-87(6)7)157(254)194-95(18)147(244)193-96(19)148(245)197-111(53-42-61-187-178(183)184)153(250)209-126(77-138(240)241)165(262)206-119(69-101-45-34-30-35-46-101)167(264)218-141(92(15)25-3)172(269)213-122(73-131(182)229)162(259)208-121(71-104-80-188-108-51-39-38-49-106(104)108)161(258)204-117(67-90(12)13)166(263)217-140(91(14)24-2)171(268)201-112(54-56-130(181)228)156(253)220-144(97(20)225)175(272)200-110(52-40-41-60-179)155(252)216-143(94(17)27-5)174(271)222-145(98(21)226)176(273)214-124(75-136(236)237)151(248)189-79-103-58-62-185-63-59-103/h29-39,43-49,51,58-59,62-63,80-81,86-99,107,109-129,140-146,188,223-227H,23-28,40-42,50,52-57,60-61,64-79,82-85,179-180H2,1-22H3,(H2,181,228)(H2,182,229)(H,186,192)(H,189,248)(H,190,246)(H,191,247)(H,193,244)(H,194,254)(H,195,230)(H,196,231)(H,197,245)(H,198,251)(H,199,260)(H,200,272)(H,201,268)(H,202,255)(H,203,261)(H,204,258)(H,205,249)(H,206,262)(H,207,266)(H,208,259)(H,209,250)(H,210,256)(H,211,267)(H,212,270)(H,213,269)(H,214,273)(H,215,257)(H,216,252)(H,217,263)(H,218,264)(H,219,274)(H,220,253)(H,221,265)(H,222,271)(H,232,233)(H,234,235)(H,236,237)(H,238,239)(H,240,241)(H,242,243)(H4,183,184,187)/t91-,92-,93-,94-,95-,96-,97+,98+,99+,107-,109?,110-,111-,112-,113-,114-,115-,116-,117-,118-,119-,120+,121-,122-,123-,124-,125-,126-,127-,128-,129-,140-,141-,142-,143-,144-,145-,146-/m0/s1 |
PubChem CID | 127051717 |
ChEMBL | CHEMBL3822792 |
IUPHAR | N/A |
BindingDB | 50183892 |
DrugBank | N/A |
Structure | |
Lipinski's druglikeness | This ligand has more than 5 hydrogen bond donor. This ligand has more than 10 hydrogen bond acceptor. This ligand is heavier than 500 daltons. |
Parameter | Value | Reference | Database source |
---|---|---|---|
EC50 | 0.04 nM | PMID26986178 | ChEMBL |
EC50 | 0.04 nM | PMID26986178 | BindingDB |
zhanglabzhanggroup.org | +65-6601-1241 | Computing 1, 13 Computing Drive, Singapore 117417